Literature DB >> 12194755

Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion.

F Roedel1, N Kley, H U Beuscher, G Hildebrandt, L Keilholz, P Kern, R Voll, M Herrmann, R Sauer.   

Abstract

PURPOSE: Low-dose radiotherapy (LD-RT) is known to exert an anti-inflammatory effect, but the underlying radiobiological and immunological mechanisms remain elusive. In recent studies, we observed a reduced adhesion of peripheral blood mononuclear cells (PBMC) to endothelial cells (EC) after LD-RT (0.3-0.7 Gy). This shows that this treatment affects the initial steps of the inflammatory response. To explore the role of inflammatory mediators in this process, we investigated the expression of Transforming growth factor beta(1) (TGF-beta(1)) and Interleukin 6 (IL-6) after LD-RT.
MATERIALS AND METHODS: EC were grown to subconfluence and irradiated with single-dose LD-RT. Twenty-hours after irradiation, EC were treated with IL-1beta for 4 h and then incubated with peripheral blood mononuclear cells (PBMC). Adherent PBMC were counted when using light microscopy. Expression of the cytokines TGF-beta(1) and IL-6 was measured by ELISA, and mRNA levels were analysed by the RNAse-protection assay (RPA). Surface expression of E-selectin was quantified by flow cytometry.
RESULTS: A relative minimum of adhesion was observed after LD-RT between 0.3 and 0.7 Gy. This was paralleled by an expression maximum of TGF-beta(1) and IL-6, as shown by protein and mRNA levels, respectively. Neutralization of TGF-beta(1) by monoclonal antibodies, but not of IL-6, increased PBMC adhesion to EC nearly to control levels. In addition, fluorescence activated cell sorter (FACS) analysis of irradiated EC demonstrated a down-regulation of E-selectin in the same dose range.
CONCLUSION: Low-dose X-irradiation between 0.3 and 0.7 Gy induced a relative maximum of TGF-beta(1) production by stimulated EC. This results in a down-regulation of leukocyte/PBMC adhesion and may contribute to the anti-inflammatory effect of LD-RT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194755     DOI: 10.1080/09553000210137671

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  30 in total

Review 1.  Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.

Authors:  M Arenas; S Sabater; V Hernández; A Rovirosa; P C Lara; A Biete; J Panés
Journal:  Strahlenther Onkol       Date:  2012-08-22       Impact factor: 3.621

2.  Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease.

Authors:  Matthew M Gestaut; Gregory P Swanson
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-25

3.  Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.

Authors:  Benjamin Prokein; Henrik Holtmann; Matthias G Hautmann; Hans-Peter Rösler; Stefan Graeber; Yvonne Dzierma; Christian Ruebe; Jochen Fleckenstein; Marcus Niewald
Journal:  Strahlenther Onkol       Date:  2017-02-27       Impact factor: 3.621

4.  Study of the anti-inflammatory effects of low-dose radiation: The contribution of biphasic regulation of the antioxidative system in endothelial cells.

Authors:  Martin Large; Stephanie Hehlgans; Sebastian Reichert; Udo S Gaipl; Claudia Fournier; Claus Rödel; Christian Weiss; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-08       Impact factor: 3.621

5.  DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.

Authors:  Berthold Reichl; Andreas Block; Ulrich Schäfer; Christoph Bert; Reinhold Müller; Horst Jung; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-28       Impact factor: 3.621

6.  Calcifying tendonitis of the shoulder joint : predictive value of pretreatment sonography for the response to low-dose radiotherapy.

Authors:  Boris Adamietz; Rüdiger Schulz-Wendtland; Sedat Alibek; Michael Uder; Rolf Sauer; Oliver Ott; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

Review 7.  Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Authors:  M P Little
Journal:  Mutat Res       Date:  2010-01-25       Impact factor: 2.433

8.  Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation.

Authors:  Franz Rödel; Benjamin Frey; Katrin Manda; Guido Hildebrandt; Stephanie Hehlgans; Ludwig Keilholz; M Heinrich Seegenschmiedt; Udo S Gaipl; Claus Rödel
Journal:  Front Oncol       Date:  2012-09-25       Impact factor: 6.244

9.  How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Authors:  Yvonne Rubner; Roland Wunderlich; Paul-Friedrich Rühle; Lorenz Kulzer; Nina Werthmöller; Benjamin Frey; Eva-Maria Weiss; Ludwig Keilholz; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2012-07-25       Impact factor: 6.244

10.  Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease.

Authors:  Jonathan W Lischalk; Seth Blacksburg; Christopher Mendez; Michael Repka; Astrid Sanchez; Todd Carpenter; Matthew Witten; Jules E Garbus; Andrew Evans; Sean P Collins; Aaron Katz; Jonathan Haas
Journal:  Radiat Oncol       Date:  2021-07-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.